ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Median lethal dose (LD50) and cytotoxicity of Adriamycin in female albino mice

Rehab M. Mosaad, Amany Samir, Hassan M. Ibrahim.




Abstract

The median lethal dose of Adriamycin and its cytotoxicity in three vital organs (heart, liver and kidney) was studied. The median lethal dose (LD50) was 56.875mg/kg b.wt. . High doses of Adriamycin induced significant increases in heart tissues enzymes (lactate dehydrogenase, alkaline phosphatase and Creatine Kinase-MB isoenzyme (CKMB)). Hepatotoxicity figured in significant increment in liver function enzymes (aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) activities) and lipid profile (cholesterol and triglycerides) and significant reduction in total protein and albumin. Moreover, urea and creatinine recorded significant increases in kidney tissues after interpretoneal administration of high doses of Adriamycin (100, 90 and 80 mg/kg b.wt.).

Key words: Median lethal dose, cytotoxicity, Adriamycin, female albino mice





publications
0
supporting
0
mentioning
0
contrasting
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.


Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.


We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More Info Got It!